Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P O'Bryan

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Science Signaling|December 16, 2010
Intersecting pathways in cell biologyJohn P O'Bryan
Pharmacological Research|October 27, 2018
Pharmacological targeting of RAS: Recent success with direct inhibitorsJohn P O'Bryan
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Probing RAS Function with MonobodiesImran Khan, John P O'Bryan
Biochimica Et Biophysica Acta. Molecular Cell Research|October 18, 2016
Intersectin scaffold proteins and their role in cell signaling and endocytosisErika Herrero-Garcia, John P O'Bryan
Journal of Visualized Experiments : Jove|April 29, 2011
Bimolecular fluorescence complementationKaty A Wong, John P O'Bryan
Advances in Cancer Research|February 1, 2022
PrefaceJohn P O'Bryan, Gary A Piazza
Seminars in Cancer Biology|December 18, 2017
Direct inhibition of RAS: Quest for the Holy Grail?Russell Spencer-Smith, John P O'Bryan
Biochemical Society Transactions|September 2, 2020
Inhibition of RAS: proven and potential vulnerabilitiesMariyam Zuberi, Imran Khan, John P O'Bryan
Biochemical Society Transactions|January 4, 2024
Intersectin - many facets of a scaffold proteinMubashir Mintoo, Vinodh Rajagopalan, John P O'Bryan
Advances in Cancer Research|February 1, 2022
Targeting the "undruggable" RAS with biologicsMichael Whaby, Imran Khan, John P O'Bryan
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Science Signaling|December 16, 2010
Intersecting pathways in cell biologyJohn P O'Bryan
Pharmacological Research|October 27, 2018
Pharmacological targeting of RAS: Recent success with direct inhibitorsJohn P O'Bryan
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Probing RAS Function with MonobodiesImran Khan, John P O'Bryan
Biochimica Et Biophysica Acta. Molecular Cell Research|October 18, 2016
Intersectin scaffold proteins and their role in cell signaling and endocytosisErika Herrero-Garcia, John P O'Bryan
Journal of Visualized Experiments : Jove|April 29, 2011
Bimolecular fluorescence complementationKaty A Wong, John P O'Bryan
Advances in Cancer Research|February 1, 2022
PrefaceJohn P O'Bryan, Gary A Piazza
Seminars in Cancer Biology|December 18, 2017
Direct inhibition of RAS: Quest for the Holy Grail?Russell Spencer-Smith, John P O'Bryan
Biochemical Society Transactions|September 2, 2020
Inhibition of RAS: proven and potential vulnerabilitiesMariyam Zuberi, Imran Khan, John P O'Bryan
Biochemical Society Transactions|January 4, 2024
Intersectin - many facets of a scaffold proteinMubashir Mintoo, Vinodh Rajagopalan, John P O'Bryan
Advances in Cancer Research|February 1, 2022
Targeting the "undruggable" RAS with biologicsMichael Whaby, Imran Khan, John P O'Bryan
Pageof 6